A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Clinical trial NCT01440374 · COMPLETED
Trial details
- NCT number
- NCT01440374
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2015-03-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.